18-49490871-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001035006.5(RPL17):c.138G>T(p.Lys46Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
RPL17
NM_001035006.5 missense
NM_001035006.5 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 0.992
Genes affected
RPL17 (HGNC:10307): (ribosomal protein L17) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L22P family of ribosomal proteins. It is located in the cytoplasm. This gene has been referred to as rpL23 because the encoded protein shares amino acid identity with ribosomal protein L23 from Halobacterium marismortui; however, its official symbol is RPL17. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream C18orf32 (chromosome 18 open reading frame 32) gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26435888).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL17 | NM_001035006.5 | c.138G>T | p.Lys46Asn | missense_variant | 4/7 | ENST00000580261.6 | NP_001030178.1 | |
RPL17-C18orf32 | NM_001199356.2 | c.24G>T | p.Lys8Asn | missense_variant | 3/7 | NP_001186285.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPL17 | ENST00000580261.6 | c.138G>T | p.Lys46Asn | missense_variant | 4/7 | 1 | NM_001035006.5 | ENSP00000462385 | P1 | |
ENST00000581232.1 | n.480-905C>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249344Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135276
GnomAD3 exomes
AF:
AC:
1
AN:
249344
Hom.:
AF XY:
AC XY:
1
AN XY:
135276
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461462Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727012
GnomAD4 exome
AF:
AC:
3
AN:
1461462
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
727012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.138G>T (p.K46N) alteration is located in exon 4 (coding exon 3) of the RPL17 gene. This alteration results from a G to T substitution at nucleotide position 138, causing the lysine (K) at amino acid position 46 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;T;T;.;T;.;.;.;.;.;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;.;.;.;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;N;N;N;N;.;N;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D
PROVEAN
Benign
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
T;D;T;T;T;T;T;T;T;T;T;T;T;.;.;.;D
Polyphen
0.075
.;.;B;B;B;B;.;B;.;.;.;.;.;.;.;.;.
Vest4
MutPred
Loss of phosphorylation at T45 (P = 0.0837);.;Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);.;Loss of phosphorylation at T45 (P = 0.0837);.;Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);Loss of phosphorylation at T45 (P = 0.0837);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at